Siemens Comos Mobile Solutions 2.0 enhances mobile information management in globally distributed engineering projects and facilitates on-line collaboration.
Image courtesy of Siemens.
Siemens Comos Mobile Solutions 2.0 with a new graphical user interface (GUI) provides context-sensitive support functions and personalized dashboards. Another feature sends warnings in the event of deviations from target. All project stakeholders can navigate to relevant plant information with the aid of quicklinks, view documents, and submit project-related inquiries using a mobile device. The ability to upload external redlining PDFs to a tablet simplifies the process of document revision and enables clearly traceable change management at any time.
The system can also be used for project management, with features such as document check-in and check-out, and an integrated task management system. The need for manual data entries is reduced by the availability of editable web attributes, as suppliers make available the information directly in the Comos interface. This feature minimizes potential sources of error and loss of data, and enhances the efficiency of the engineering project, particularly when a large number of suppliers are involved.
Source: Siemens
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.